If boosters become available to everyone, vaccine makers are on track to make billions.
Though President Joe Biden’s administration has made it seem that everyone could get the booster, the FDA and CDC have rejected the plan.
Leaders believe it will only be a matter of time before the boosters become more widely available.
If it becomes more broad on top of the increase in vaccinations, Pfizer and Moderna specifically will make a large profit.
Moderna’s projected revenue for 2022 jumped 35% when Biden announced the booster shot plans in August.
While the number of people who will end up getting booster shots has yet to be determined, Morningstar analyst Karen Andersen believes boosters will bring $26 billion in for Pfizer and $14 billion for Moderna.
The revenue coming in for COVID-19 vaccines and boosters has already greatly surpassed many other vaccines, including AbbVie’s rheumatoid arthritis treatment Humira, which is the best selling drug on the market globally.
Make FL1 part of your day.
Local reporting. Useful updates. More ways to stay close to your community.
Go ad-free
Support independent local reporting and enjoy FL1 without display ads.
$4.99 / month
Become a member →Cancel anytime. Third-party media players may contain ads.Get the daily briefing
Start your morning with the headlines that matter across the Finger Lakes.
Find more FL1 on Google
Choose FingerLakes1.com as a preferred source to see more of our reporting in your Google news results.




